All In Biotech

Drug Trial Radar · NCT06267560

Lp(a) Lowering Study of Pelacarsen (TQJ230) in US Black/African American and Hispanic Participants With Elevated Lp(a) and Established ASCVD

A Randomized Double-blind, Placebo-controlled, Multicenter Study to Evaluate the Efficacy, Safety and Tolerability of Pelacarsen (TQJ230) in US Black/African American & Hispanic Patient Populations With Elevated Lp(a) and Established Atherosclerotic Cardiovascular Disease

Last checked: Nov 19, 2026Latest source record: Aug 10, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingPhase 3. Randomized with 422 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

422

Actual

Start

Apr 24, 2024

Primary completion

Mar 25, 2026

Study completion Mar 25, 2026

Sponsor

Lead sponsor
Novartis PharmaceuticalsNovartis (NVS)
Sponsor type
Industry
First posted
Feb 20, 2024

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years, up to 80 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

Study CTQJ230A12303 is a randomized, double-blind placebo-controlled, Phase IIIb study to evaluate the efficacy, safety and tolerability of pelacarsen (TQJ230) 80 mg s.c. QM compared with placebo s.c. QM in US Black/African American and Hispanic participants with established ASCVD and elevated levels of Lp(a) who are treated for cardiovascular (CV) risk factors according to local practice/guidelines for the reduction of cardiovascular risk.

Conditions

  • Elevated Lp(a) and Established Atherosclerotic Cardiovascular Disease

Interventions

  • TQJ230Drug

    TQJ230 80mg QM s.c.

  • PlaceboDrug

    matching placebo

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Change in log-transformed Lp(a) concentration from baseline at week 52Time frame: Baseline, week 52

Locations

96 sites in 2 countries. Site status is shown where the registry gives one.

  • Parkway Medical Center

    Birmingham, Alabama

  • Cardiology and Medicine Clinic PA

    Little Rock, Arkansas

  • National Heart Institute

    Beverly Hills, California

  • Alliance Clinical

    Canoga Park, California

  • Valley Clinical Trials Inc

    Covina, California

  • NICRs Research Center

    Garden Grove, California

  • University of Calif Irvine Med Cntr

    Irvine, California

  • Long Beach Clinical Trials

    Long Beach, California

  • Angel City Research Inc

    Los Angeles, California

  • California Medical Research Associates Inc

    Northridge, California

  • Stanford University Medical Center

    Palo Alto, California

  • Acclaim Clinical Research

    San Diego, California

  • Excel Medical Clinical Trials LLC

    Boca Raton, Florida

  • C and A Clinical Trials

    Cape Coral, Florida

  • Proactive Clinical Research

    Fort Lauderdale, Florida

  • National Research Institute

    Hialeah, Florida

  • Sister Life Research Inc

    Hialeah, Florida

  • Zenith Clinical Research

    Hollywood, Florida

  • Columbus Clinical Services LLC

    Miami, Florida

  • Finlay Medical Research

    Miami, Florida

  • Infinite Clinical Research

    Miami, Florida

  • Flourish Research Miami LLC

    Miami, Florida

  • International Research Associates LLC

    Miami, Florida

  • Baptist Health South

    Miami, Florida

  • A&A Research Group Inc

    Miami, Florida

  • Inpatient Research Clinical LLC

    Miami Lakes, Florida

  • FXM Clin Res Miramar LLC

    Miramar, Florida

  • CTMD Research

    Palm Springs, Florida

  • DBC Research USA

    Pembroke Pines, Florida

  • New Tampa Health

    Tampa, Florida

  • James A Haley Veterans Hospital

    Tampa, Florida

  • Cardiology Partners Clinical Research Institute

    Wellington, Florida

  • Flourish Research

    Winter Park, Florida

  • Morehouse School Of Medicine

    Atlanta, Georgia

  • Atlanta Heart Specialists LLC

    Tucker, Georgia

  • Synexus Clinical Research US Inc

    Chicago, Illinois

  • Chicago Clinical Research Inst

    Chicago, Illinois

  • Cardiovascular Associates Research

    Covington, Louisiana

  • Omega Clinical Research

    Metairie, Louisiana

  • CV Ins of the South

    Opelousas, Louisiana

Showing 40 of 96 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.